http://bit.ly/2AbPxuj

The US Food and Drug Administration has issued 14 observations after inspecting the drug firm's manufacturing facility at Moraiya in Ahmedabad.

from Markets http://bit.ly/2Vf2obE

Comments

Popular posts from this blog

CAG flags tax irregularities by banks, NBFCs

IIT PhDs in demand for high-end R&D jobs

India Inc turn to non-bank routes for funding